Nonpregnant vaginal bleeding: Difference between revisions

(Text replacement - "Hb" to "hemoglobin")
(29 intermediate revisions by 6 users not shown)
Line 1: Line 1:
==Background==
==Background==
*This page is for the generalized approach to undifferentiated vaginal bleeding in non-pregnant women
*Normal menstruation:
*Normal menstruation:
**28 +/- 7d cycles; 4d of bleeding  
**28 +/- 7 day cycles
===Definitions===
**4 days of bleeding  
#Menorrhagia
**Usual amount bleeding per period 10-35 cc
##Prolonged (>7d) or excessive (>60mL daily) vaginal bleeding at regular intervals
**Each normal sized tampon or pad holds 5 cc when soaked through
#Metrorrhagia
##Irregular vaginal bleeding outside the normal cycle
#Menometrorrhagia
##Excessive irregular vaginal bleeding
#Polymenorrhea
##Frequent and light bleeding
#Postcoital bleeding
##Vaginal bleeding after intercourse, suggesting cervical pathology
#Postmenopausal bleeding
##Any bleeding that occurs >6 mo after cessation of menstruation
#Dysfunctional uterine bleeding
##Bleeding not due to an organic cause


==Diagnosis==
{{Vaginal bleeding definitions}}
*Hemodynamically stable pt in ED must rule-out:
 
==Clinical Features==
*Vaginal bleeding in a non-pregnant woman
 
==Differential Diagnosis==
{{VB DDX nonpregnant}}
 
==Evaluation==
===Work-Up===
*Urine pregnancy
*hemoglobin
*Coags (only if history of or suspect coaulopathy)
*?TSH, prolactin (only if suspect endocrine disorder)
*Consider follow up for non-emergent [[pelvic ultrasound]]
**No indication for emergent ultrasound in ED
 
===Evaluation===
*Hemodynamically stable patient in ED must rule-out:
**Pregnancy
**Pregnancy
**Trauma
**Trauma
Line 25: Line 31:
**Infection
**Infection
**Retained foreign body
**Retained foreign body
**If work up negative, can refer for further outpatient work up


 
==Management==
*Obtain coags only if suspect bleeding dyscrasia
{{Non pregnant vaginal bleeding treatment}}
*Obtain TSH, prolactin levels if suspect endocrine d/o
 
==DDX==
===Systemic Causes===
#Secondary anovulation
#Coagulopathy
##Von Willebrand, ITP
#Hypothyroidism
#Hormone replacement therapy
#Cirrhosis
 
===Reproductive Tract Causes===
#Fibroids
#Adenomyosis
#Endometriosis
#Neoplasia
#Infection (vaginitis, PID)
#Vaginal trauma
#Foreign Body
#IUD
#Atrophic endometrium
#Dysfunctional uterine bleeding
##Diagnosis of exclusion
##Ovulatory: Excessive wt change, stress, exercise
##Anovulatory: postmenopause, premenopause, PCOS
 
==Work-Up==
#Urine pregnancy
#Hb
#Coags (only if h/o or suspect coaulopathy)
#?TSH
#?Pelvic u/s
 
==Treatment==
#Gyn consult
#Estrogen IV/PO (similar efficacy)
#Temporize bleeding w/ foley balloon or kerlix soaked in saline and thrombin
#Suture or silver nitrate if bleeding from trauma


==Disposition==
==Disposition==
*D/c home w/ OB/GYN f/u
*Most can be discharged home with OB/GYN follow-up
 
*For severe anemia or persistent exceedingly heavy flow, consider admission and/or discussion with OB/GYN
==Source==
Tintinalli


==References==
<references/>


==See Also==
==See Also==
[[Vaginal Bleeding (Main)]]
*[[Vaginal Bleeding (Main)]]


[[Category:OB/GYN]]
[[Category:OBGYN]]

Revision as of 06:37, 1 August 2016

Background

  • This page is for the generalized approach to undifferentiated vaginal bleeding in non-pregnant women
  • Normal menstruation:
    • 28 +/- 7 day cycles
    • 4 days of bleeding
    • Usual amount bleeding per period 10-35 cc
    • Each normal sized tampon or pad holds 5 cc when soaked through

Vaginal bleeding definitions

  • Menorrhagia: >7 day (prolonged) or >80 mL/day (excessive) uterine bleeding at regular intervals
  • Metrorrhagia: irregular vaginal bleeding outside the normal cycle
  • Menometrorrhagia: excessive irregular vaginal bleeding
  • Intermenstrual bleeding: variable amounts between regular menstrual periods
  • Midcycle spotting: spotting just before ovulation (due to decline in estrogen)
  • Polymenorrhea: frequent and light bleeding
  • Postcoital bleeding: vaginal bleeding after intercourse, suggesting cervical pathology
  • Postmenopausal bleeding: recurrence of bleeding >6 mo after menopause
  • Amenorrhea: bleeding that is absent for > 6 months

Clinical Features

  • Vaginal bleeding in a non-pregnant woman

Differential Diagnosis

Nonpregnant Vaginal Bleeding

Systemic Causes

Reproductive Tract Causes

Evaluation

Work-Up

  • Urine pregnancy
  • hemoglobin
  • Coags (only if history of or suspect coaulopathy)
  • ?TSH, prolactin (only if suspect endocrine disorder)
  • Consider follow up for non-emergent pelvic ultrasound
    • No indication for emergent ultrasound in ED

Evaluation

  • Hemodynamically stable patient in ED must rule-out:
    • Pregnancy
    • Trauma
    • Bleeding dyscrasia
    • Infection
    • Retained foreign body
    • If work up negative, can refer for further outpatient work up

Management

Mild Bleeding

  • Iron supplementation
    • 324mg ferrous sulfate tablet PO TID (each tab contains 65mg of elemental iron)
  • NSAIDs
    • e.g. ibuprofen 400 mg PO q6h, or naproxen 500 mg PO BID
    • For cramping pain and can decreases intra-uterine bleeding. Reduces endometrial prostaglandin levels and promotes vasoconstriction in the uterus

Moderate continued bleeding

Patients may benefit from initiation of short or long-term birth control for acute cessation.

Combined OCPs

  • Any combined OCP that contains 35 ug of ethinyl estradiol TID for 7 days. (e.g., Ortho-Novum 1/35®)[1]
    • 88% success, median time 3 days [2]
  • Contraindications
    • Cigarette smoking if older than 34 years
    • Hypertension
    • History of VTE
    • Cerebrovascular disease
    • CAD or valvular disease
    • History of breast cancer
    • Diabetes with vascular involvement
    • Surgery with immobilization
    • Liver cirrhosis
    • Other pro-coagulative conditions (e.g. Lupus, Factor V Leiden)

Medroxyprogesterone

  • 20 mg PO TID for 7 days[1]
    • 76% success, median time 3 days
  • Alternative, not officially endorsed by ACOG: 150mg IM x 1 then 20 mg PO TID x 3 days
    • In a trial of 48 patients all had cessation in 5 days.[3]
  • Contraindications
    • History of VTE
    • History of arterial thromboembolic events
    • History of breast cancer
    • Liver disease


If you are concerned for malignancy, hormonal therapy should be avoided until patient can be evaluated by OBGYN for possible biopsy, since these medications can interfere with those results.

Life Threatening

  • Establish large bore IV access
  • Prepare for emergent blood transfusion uncrossmatched O-negative blood if typed blood is not available.
  • It is possible to temporize bleeding w/ intravaginal packing with kerlix soaked in with thrombin
  • If bleeding is due to a traumatic cause emergent surgical repair is necessary
  • Tranexamic acid [4]
    • Coordinate with OBGYN prior to administration due to the increased thrombotic risk
    • Acutely 1.0-1.3 grams IV
    • Then 1-1.3 g TID PO for 5 days

Pharmacologic Treatment Regimens For Acute Abnormal Uterine Bleeding[5][6]

Drug Suggested Dose Contraindications
Conjugated equine estrogen 25 mg IV every 4-6 h until bleeding stops, up to 24 h Active or past thromboembolic disease, breast cancer, or liver disease
Combination oral contraceptive pills 1 pill TID PO for 7 days or 1 pill bid PO for 5 days, then 1 pill daily until pack is finished > 35 y who smoke, history of DVT or PE, breast cancer, liver disease, known thromboembolic disorders, pregnancy, ischemic heart disease, cerebrovascular disease, or uncontrolled hypertension
Progestin-only oral contraceptive pills (medroxyprogesterone acetate) 20 mg TID PO for 7 days or 10 mg daily PO for 10 days Active or past DVT or PE, liver disease, or breast cancer
NSAIDs: Ibuprofen 200-400 mg 3-4 times/day PO for 5 days Advanced renal disease
Antifibrinolytic agents (tranexamic acid) 1.3 g TID PO for up to 5 days Active intravascular clotting or subarachnoid hemorrhage

Disposition

  • Most can be discharged home with OB/GYN follow-up
  • For severe anemia or persistent exceedingly heavy flow, consider admission and/or discussion with OB/GYN

References

  1. 1.0 1.1 Management of acute abnormal uterine bleeding in nonpregnant reproductive-aged women. Committee Opinion No. 557. American College of Obstetricians and Gynecologists. Obstet Gynecol 2013; 121:891–6. https://www.acog.org/clinical/clinical-guidance/committee-opinion/articles/2013/04/management-of-acute-abnormal-uterine-bleeding-in-nonpregnant-reproductive-aged-women
  2. Munro MG, Mainor N, Basu R, Brisinger M, Barreda L. Oral medroxyprogesterone acetate and combination oral contraceptives for acute uterine bleeding: a randomized controlled trial. Obstet Gynecol. 2006 Oct;108(4):924-9. doi: 10.1097/01.AOG.0000238343.62063.22. PMID: 17012455.
  3. Ammerman SR, Nelson AL. A new progestogen-only medical therapy for outpatient management of acute, abnormal uterine bleeding: a pilot study. Am J Obstet Gynecol. 2013. 208(6):499.e1-e5.
  4. Leminen and Hurskainen. Tranexamic acid for the treatment of heavy menstrual bleeding: efficacy and safety. Int J Womens Health. 2012; 4: 413–421.
  5. American College of Obstetricians and Gynecologists. ACOG Committee Opinion No. 557: management of acute abnormal uterine bleeding in nonpregnant reproductiveaged women. Obstet Gynecol. 2013;121(4):891-896
  6. Tibbles CD. Selected gynecologic disorders: abnormal uterine bleeding in the nonpregnant patient. In: Marx JA, Hockberger RS, Walls RM, eds. Rosen’s Emergency Medicine: Concepts and Clinical Practice. Philadelphia, PA: Mosby-Elsevier; 2010: 1325-1332.

See Also